Tag Archives: Moderna

Moderna (MRNA) has its sights set on 2022 and beyond, even as it continues to produce doses for its COVID-19 vaccine this year. CEO Stéphane Bancel told Yahoo Finance Wednesday that governments are now focused on booster shots for next year, even though it’s unclear what type of booster shot will be needed — or when it will be needed — as worries surface over emerging variants.  The pandemic still continues to claim casualties around the world, challenging efforts by the U.S., Britain… Source link

Pfizer (PFE) and BioNTech’s (BNTX) COVID-19 vaccine is proving effective six months after the second dose, according to an ongoing analysis of the Phase 3 trial participants. The vaccine showed 91.3% efficacy against COVID-19, slightly lower than the original 95% seen in Phase 3 trials. The data, from 12,000 of the more than 44,000 adults in the trial, is a result of observations from seven days through six months after the second dose was received. The two companies announced the results in a… Source link

TipRanks Billionaire Steven Cohen Picks Up These 3 “Strong Buy” Stocks Last week, the NASDAQ slipped below 13,200, making the net loss from its all-time peak, reached earlier this month, 6.4%. If this trend keeps up, the index will slip into correction territory, a loss of 10% from its peak. So what exactly is going on? At bottom, it’s mixed signals. The COVID-19 pandemic is starting to fade and the economy is starting to reopen – strong positives that should boost markets. But an… Source link

TipRanks Billionaire Steven Cohen Picks Up These 3 “Strong Buy” Stocks Last week, the NASDAQ slipped below 13,200, making the net loss from its all-time peak, reached earlier this month, 6.4%. If this trend keeps up, the index will slip into correction territory, a loss of 10% from its peak. So what exactly is going on? At bottom, it’s mixed signals. The COVID-19 pandemic is starting to fade and the economy is starting to reopen – strong positives that should boost markets. But an… Source link

In this episode of Yahoo Finance Presents Moderna CEO Stéphane Bancel, talks to Yahoo Finance senior reporter Anjalee Khemlani about the company’s new boosters for COVID-19 variant strands as well as the continued rollout of their vaccines. Video Transcript [MUSIC PLAYING] ANJALEE KHEMLANI: Joining me now is Stephane Bancel, CEO of Moderna. Stephane, thank you so much for joining me today. STEPHANE BANCEL: Thank you so much for having us. ANJALEE KHEMLANI: So great news, you have the booster… Source link

TipRanks 3 ‘Strong Buy’ Stocks With 8% Dividend Yield Let’s talk portfolio defense. After last week’s social flash mob market manipulation, that’s a topic that should not be ignored. Now, this is not to say that the markets are collapsing. After 2% losses to close out last week’s Friday session, this week’s trading kicked off with a positive tone, as the S&P 500 rose 1.5% and the Nasdaq climbed 2.5%. The underlying bullish factors – a more stable political scene, steadily… Source link

TipRanks 3 Stocks J.P. Morgan Says Are Ready to Rip Higher Take a deep breath, get ready, the New Year is just around the corner, and while we’re all ready to celebrate – just on principle, because getting out of 2020 is reason enough for joy – let’s also take stock of where we are and where we’re headed.There’s a growing sense of optimism, engendered by the availability of COVID vaccines and the potential they give for a return to normal on Main Streets around the country…. Source link

TipRanks 3 Stocks Flashing Signs of Strong Insider Buying Sometimes, following a leader makes the best investment strategy. And corporate insiders have long been popular leaders to follow. Their combination of responsibility to their stockholders and access to ‘under the hood’ information on their companies gives their personal investment choices an air of authority.The most important thing about these insiders is that whatever else they do, they are expected to shepherd their companies to… Source link

Moderna’s (MRNA) COVID-19 was recommended for emergency use authorization (EAU) Thursday evening by an advisory committee to the U.S. Food and Drug Administration (FDA) in a majority vote, with just one abstention. The vote brings the company one step closer to becoming the second authorized vaccine in the U.S. The advisory panel voted to allow use in adults 18 and older, including first-priority frontline health workers and nursing home residents. For Moderna, the widely-expect… Source link

TipRanks J.P. Morgan: 2 Stocks to Buy (And 1 to Avoid) Marko Kolanovic, the well-known quant strategist with JPMorgan, sees a positive feedback loop forming that will drive the markets higher next year. Kolanovic believes that a decline in volatility and favorable monetary policies will combine to make stocks the go-to investment for 2021, fueling further market gains. Officially, JPM is forecasting a 25% gain in the S&P 500 over the next 12 months.With investors gravitating toward stocks,… Source link